Japan investigates cancer "articles"

Share this article:

Japan's Health, Labor and Welfare Ministry is investigating a series of advertorials that were dressed up as articles but were in fact cancer-drug marketing efforts. Pharmalot reports that five unnamed drugmakers paid $18,500-$56,300 for articles in an unnamed publication so their cancer drugs would be slipped into articles. The setup is similar to television and movie product placement: the magazine wrote the article, entered quotes and plugged in drug names depending on payment.

Pharmalot says the publisher says everything done was legally.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Ranbaxy extends branded Diovan's life

Ranbaxy may be on the blocks, but it has a hold on the right to produce generics of the Novartis heart medication Diovan. Only problem: it can't, and that is good news for Novartis.

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.